• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Conatus Pharmaceuticals Inc. (CNAT)

    -NasdaqGM
    5.36 Up 0.04(0.75%) May 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:5.32
    Open:5.32
    Bid:N/A
    Ask:5.45 x 500
    1y Target Est:13.57
    Beta:-0.520
    Earnings Date:Aug 11 - Aug 17 (Est.)
    Day's Range:5.25 - 5.45
    52wk Range:5.22 - 11.74
    Volume:195,633
    Avg Vol (3m):688,508
    Market Cap:105.79M
    P/E (ttm):N/A
    EPS (ttm):-1.44
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CNAT

    Comparison

    Symbol% ChgMkt Cap
    CNATUp 0.75%105.79M
    GALTUp 1.48%64.98M
    ICPTDown 1.59%6.29B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.58
    Quarterly EPS Est (Jun-15) :-0.34
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-3.37

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback